Showing 281 - 300 results of 1,716 for search '"Tenofovir"', query time: 0.14s Refine Results
  1. 281

    Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir by Suzuki F, Sezaki H, Akuta N, Suzuki Y, Kawamura Y, Hosaka T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Watahiki S, Mineta R, Suzuki Y, Kumada H

    Published 2014-06-01
    “…Fumitaka Suzuki,1,2 Hitomi Sezaki,1 Norio Akuta,1 Yoshiyuki Suzuki,1 Yusuke Kawamura,1 Tetsuya Hosaka,1 Masahiro Kobayashi,1 Satoshi Saitoh,1 Yasuji Arase,1 Kenji Ikeda,1 Mariko Kobayashi,3 Sachiyo Watahiki,3 Rie Mineta,3 Yukiko Suzuki,3 Hiromitsu Kumada1 1Department of Hepatology, Toranomon Hospital, Tokyo, Japan; 2Okinaka Memorial Institute for Medical Research, Tokyo, Japan; 3Research Institute for Hepatology, Toranomon Branch Hospital, Kawasaki, Japan Abstract: Tenofovir disoproxil fumarate (TDF) is widely used to treat hepatitis B virus (HBV) patients in the USA and Europe. …”
    Get full text
    Article
  2. 282
  3. 283
  4. 284
  5. 285

    Incapacitating pain from Tenofovir Induced Hypophosphatemic Osteomalacia in a Hemophilia Patient – A Case Report by Emma Woo, Dinesh Kumbhare, Paul Winston

    Published 2020-01-01
    “…Results: With termination of tenofovir treatment, this patient returned to baseline function. …”
    Get full text
    Article
  6. 286
  7. 287
  8. 288
  9. 289
  10. 290

    Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study by Javier Perez Stachowski, David Rial Crestelo, Ana Moreno Zamora, Noemi Cabello, Pablo Ryan, Nuria Espinosa Aguilera, Otilia Bisbal, Maria Jesus Vivancos Gallego, Maria Jose Nuñez, Jesus Troya, Montserrat Dominguez, Julian Olalla Sierra

    Published 2022-08-01
    “…Design: Phase IV, multicentric, open-label, single-arm clinical trial of participants recruited in 2018–2019 to evaluate the efficacy and safety of tenofovir alafenamide/emtricitabine/elvitegravir-cobicistat (TAF/FTC/EVG-c) as first-line treatment in HIV-1 infected naïve participants with advanced disease. …”
    Get full text
    Article
  11. 291
  12. 292

    Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B by Te-Sheng Chang, Yao-Hsu Yang, Wei-Ming Chen, Chien-Heng Shen, Shui-Yi Tung, Chih-Wei Yen, Yung-Yu Hsieh, Chuan-Pin Lee, Meng-Ling Tsai, Chao-Hung Hung, Sheng-Nan Lu

    Published 2021-01-01
    “…Abstract It remains controversial whether entecavir (ETV) and tenofovir disoproxil fumarate (TDF) is associated with different clinical outcomes for chronic hepatitis B (CHB). …”
    Get full text
    Article
  13. 293
  14. 294
  15. 295

    Evaluation of Renal Adverse Effects of Combination Anti-retroviral Therapy including Tenofovir in HIV-infected Patients by Hiroyuki Tanaka, Mariko Arai, Yoshinori Tomoda, Tatsuhiko Wada, Kazuo Yago, Mitsutoshi Satoh

    Published 2013-05-01
    “…Although the nucleoside/nucleotide reverse transcriptase inhibitor, tenofovir disoproxil fumarate (TDF) is a first-line drug commonly used, it is associated with renal dysfunction. …”
    Get full text
    Article
  16. 296

    A multicompartment population PK model to predict tenofovir and emtricitabine mucosal tissue concentrations for HIV prevention by Erick Leung, Mackenzie L. Cottrell, Craig Sykes, Nicole White, Angela D. M. Kashuba, Julie B. Dumond

    Published 2023-12-01
    “…Healthy female volunteers were given a single oral dose of tenofovir disoproxil fumarate (150, 300, or 600 mg) or emtricitabine (100, 200, or 400 mg). …”
    Get full text
    Article
  17. 297
  18. 298
  19. 299
  20. 300